Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 2 |
STJ
St Jude Medical
STJ
|
+$235M |
| 3 |
JPMorgan Chase
JPM
|
+$211M |
| 4 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIO
6076
DELISTED
City Office REIT
CIO
| $7K | ﹤0.01% |
+641
| New | +$8.07K |
|
6077
Century Casinos
CNTY
$33.2M
| $7K | ﹤0.01% |
907
-1,227
| -57% | -$8.89K |
|
6078
Daktronics
DAKT
$941M
| $7K | ﹤0.01% |
731
-3,090
| -81% | -$30.5K |
|
6079
CALL
Edgewell Personal Care
EPC
$1.26B
| $7K | ﹤0.01% |
100
-6,800
| -99% | -$518K |
|
6080
CALL
Ericsson
ERIC
$32.1B
| $7K | ﹤0.01% |
1,000
-6,400
| -86% | -$39.5K |
|
6081
PUT
iShares MSCI Australia ETF
EWA
$1.41B
| $7K | ﹤0.01% |
300
-2,900
| -91% | -$63.2K |
|
6082
PUT
Four Corners Property Trust
FCPT
$2.8B
| $7K | ﹤0.01% |
294
-1,617
| -85% | -$34.7K |
|
6083
Forestar Group
FOR
$1.47B
| $7K | ﹤0.01% |
565
-45,452
| -99% | -$595K |
|
6084
Global Indemnity Group
GBLI
$402M
| $7K | ﹤0.01% |
163
+41
| +34% | +$1.57K |
|
6085
GeoPark
GPRK
$622M
| $7K | ﹤0.01% |
+954
| New | +$5.23K |
|
6086
PUT
iShares Core S&P Small-Cap ETF
IJR
$110B
| $7K | ﹤0.01% |
100
-2,300
| -96% | -$159K |
|
6087
PUT
IMAX
IMAX
$2.61B
| $7K | ﹤0.01% |
200
-3,900
| -95% | -$127K |
|
6088
Lineage Cell Therapeutics
LCTX
$277M
| $7K | ﹤0.01% |
2,683
+464
| +21% | +$1.32K |
|
6089
Lifecore Biomedical
LFCR
$164M
| $7K | ﹤0.01% |
541
-306
| -36% | -$3.87K |
|
6090
PUT
LGI Homes
LGIH
$1.33B
| $7K | ﹤0.01% |
200
-100
| -33% | -$3.05K |
|
6091
Live Oak Bancshares
LOB
$1.97B
| $7K | ﹤0.01% |
339
-209
| -38% | -$4.43K |
|
6092
PUT
MidCap Financial Investment
MFIC
$796M
| $7K | ﹤0.01% |
333
-34
| -9% | -$630 |
|
6093
Mistras Group
MG
$483M
| $7K | ﹤0.01% |
325
-120
| -27% | -$2.72K |
|
6094
CALL
MKS Inc
MKSI
$19.8B
| $7K | ﹤0.01% |
100
| – | – |
|
6095
Mesa Laboratories
MLAB
$558M
| $7K | ﹤0.01% |
58
-86
| -60% | -$10.5K |
|
6096
CALL
Puma Biotechnology
PBYI
$402M
| $7K | ﹤0.01% |
200
-3,700
| -95% | -$135K |
|
|
PHX
6097
DELISTED
PHX Minerals
PHX
| $7K | ﹤0.01% |
371
-229
| -38% | -$4.7K |
|
6098
PUT
Plug Power
PLUG
$2.92B
| $7K | ﹤0.01% |
5,000
-31,100
| -86% | -$35.7K |
|
6099
PUT
ProShares Short S&P500
SH
$913M
| $7K | ﹤0.01% |
50
| – | – |
|
6100
SELLAS Life Sciences
SLS
$2.02B
| $7K | ﹤0.01% |
+8
| New | +$13.2K |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $380M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.